Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 106, Issue 7, Pages 2307-2312Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0810059106
Keywords
anti-microbial immunity; antigen cross-presentation
Categories
Funding
- Swiss National Science Foundation
- European Framework Program
- Cancer Research Institute
- Swiss National Science Foundation fellowship
Ask authors/readers for more resources
gamma delta T cells are implicated in host defense against microbes and tumors but their mode of function remains largely unresolved. Here, we have investigated the ability of activated human V gamma 9V delta 2(+) T cells ( termed gamma delta T-APCs) to cross-present microbial and tumor antigens to CD8(+) alpha beta T cells. Although this process is thought to be mediated best by DCs, adoptive transfer of ex vivo antigen-loaded, human DCs during immunotherapy of cancer patients has shown limited success. We report that gamma delta T-APCs take up and process soluble proteins and induce proliferation, target cell killing and cytokine production responses in antigen-experienced and naive CD8(+) alpha beta T cells. Induction of APC functions in V gamma 9V delta 2(+) T cells was accompanied by the up-regulation of costimulatory and MHC class I molecules. In contrast, the functional predominance of the immunoproteasome was a characteristic of gamma delta T cells irrespective of their state of activation. gamma delta T-APCs were more efficient in antigen cross-presentation than monocyte-derived DCs, which is in contrast to the strong induction of CD4(+) alpha beta T cell responses by both types of APCs. Our study reveals unexpected properties of human gamma delta T-APCs in the induction of CD8(+) alpha beta T effector cells, and justifies their further exploration in immunotherapy research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available